Issue : The Pharmaceutical Journal, April 2020, Vol 304, No 7936
Sort by: Newest first Oldest first A-Z Z-A
-
Spotting the signs of acute kidney injury Subscription
With 65% of cases beginning in the community, pharmacists can help detect acute kidney injury early and review patients’ medicines before their condition worsens.
-
How to keep your community pharmacy running during the COVID-19 pandemic
How pharmacists can implement guidance and best practice in response to the rapidly changing COVID-19 pandemic to ensure patient and staff safety, as well as the approaches pharmacy teams across the UK are taking in response to the virus.
-
Why we should be wary of 'game-changing' claims about COVID-19 treatments
Dozens of drug candidates are being trialled for both prophylaxis and treatment of COVID-19, but it is too early to recommend any of them for routine clinical use.
-
Do I have the skills to work for a primary care network? Subscription
With opportunities to work in primary care networks emerging in England, pharmacists can make the most of their knowledge and experience to succed in such a role.
-
Unclear if antiretrovirals help against COVID-19, initial assessment concludes
There is insufficient evidence in the literature to indicate whether antiretroviral medicines are effective in treating or preventing coronavirus infections, the authors of a systematic review have concluded.
-
How the Royal Pharmaceutical Society is working to support pharmacists through the COVID-19 pandemic
Since announcing it would be exclusively focusing its resources on supporting members through the COVID-19 outbreak for the foreseeable future, the Royal Pharmaceutical Society has been striving for better support for the profession across England, Scotland and Wales.
-
Are pharmacy teams being protected against COVID-19?
When Public Health England published new guidance on the use of personal protective equipment during the COVID-19 pandemic on 2 April 2020, pharmacy’s representative bodies thought the battle was won.
-
Ways to safeguard UK drug supplies during COVID-19 and beyond
The COVID-19 pandemic is stretching the NHS, including its supplies of essential drugs, to the limits. We may need new systems in place to ensure patients never miss out on medicines they need.
-
Some pharmacies turn down offer of NHS volunteers for deliveries
Some pharmacies have said they will not use NHS volunteers for delivering medicines to vulnerable patients during the COVID-19 pandemic, after guidance from the Pharmaceutical Services Negotiating Committee has stated they would be responsible for ensuring that safety checks on volunteers had been carried out.
-
COVID-19 death rate under 1% when unconfirmed cases considered, researchers estimate
The estimated death rate from COVID-19 is 0.66% when unconfirmed cases are taken into account, researchers have calculated.
Show 10 per page20 per page50 per page
